Rapid Serological Tests and Immunity Policies: Addressing Ethical Implications for Healthcare Providers and the Healthcare System as a Priority

Keywords: public health, healthcare providers, serological tests, COVID-19, ethics

Abstract

Healthcare providers (HCP) have been central actors in containing the COVID-19 pandemic. Although potentially very beneficial, the implementation of large-scale rapid serological tests raises ethical dilemmas and affects HCPs’ capacity to work in optimal conditions. In this regard, we call for attention to address specific and urgent ethical issues distinctively affecting HCPs following the availability and possible mandatory use of rapid serological tests for COVID-19.

Published
2020-11-16
How to Cite
[1]
Masella M-A, Gallois H, Bélisle-Pipon J-C. Rapid Serological Tests and Immunity Policies: Addressing Ethical Implications for Healthcare Providers and the Healthcare System as a Priority. Can. J. Bioeth. 2020;3:177-9. https://doi.org/10.7202/1073796ar.
Section
Perspectives